20017, Washington, District of Columbia Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 20017, Washington, District of Columbia is 75 when comparing 34,000 ZIP Codes in the United States.

An estimate of 94.64 percent of the residents in 20017 has some form of health insurance. 36.63 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 70.69 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 20017 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 4,221 residents under the age of 18, there is an estimate of 138 pediatricians in a 20-mile radius of 20017. An estimate of 29 geriatricians or physicians who focus on the elderly who can serve the 3,193 residents over the age of 65 years.

In a 20-mile radius, there are 22,296 health care providers accessible to residents in 20017, Washington, District of Columbia.

Prostate cancer is a significant health concern, and access to quality care is paramount. This analysis delves into the landscape of prostate cancer care within ZIP Code 20017, focusing on physician availability, healthcare resources, and overall quality of care, while also considering the broader context of primary care availability in Washington, D.C.

The assessment begins with a critical examination of physician-to-patient ratios. ZIP Code 20017, encompassing parts of the nation's capital, presents a unique demographic profile. The ratio of urologists, the specialists primarily responsible for prostate cancer diagnosis and treatment, to the population within this area is a crucial indicator of accessibility. A higher ratio, indicating more urologists per capita, generally translates to easier access to appointments, consultations, and timely interventions. Conversely, a lower ratio can lead to longer wait times and potentially delayed diagnoses.

The availability of primary care physicians (PCPs) also plays a vital role. PCPs are often the first point of contact for patients experiencing symptoms or concerned about their prostate health. Their ability to conduct initial screenings, order necessary tests, and refer patients to specialists is essential for early detection and effective management. The analysis considers the density of PCPs within the area, assessing whether the existing primary care infrastructure can adequately support the population's needs.

Beyond physician availability, the quality of care is influenced by several factors. The analysis examines the presence of standout practices and hospitals within and near ZIP Code 20017. This involves evaluating their reputation, patient outcomes, and the availability of advanced diagnostic and treatment options. Hospitals with comprehensive cancer centers, offering services like radiation therapy, brachytherapy, and robotic-assisted surgery, are considered highly favorable. The presence of multidisciplinary teams, including urologists, oncologists, radiologists, and nurses, is also a significant indicator of quality care.

Telemedicine adoption is another critical aspect of modern healthcare delivery. The ability to conduct virtual consultations, follow-up appointments, and remote monitoring can significantly improve patient access and convenience, especially for those with mobility issues or living in areas with limited access to specialists. The analysis assesses the extent to which healthcare providers in the area have embraced telemedicine technologies, including the availability of virtual appointments, remote patient monitoring systems, and online patient portals.

Mental health resources are often overlooked but are integral to comprehensive cancer care. A prostate cancer diagnosis can be emotionally taxing, leading to anxiety, depression, and other mental health challenges. The analysis examines the availability of mental health services, including therapists, counselors, and support groups, specifically tailored to the needs of prostate cancer patients. The integration of mental health support into the overall care plan is a key indicator of a patient-centered approach.

The analysis also considers the availability of patient education and support resources. Access to information about prostate cancer, its diagnosis, treatment options, and potential side effects is crucial for empowering patients to make informed decisions about their care. The presence of patient education materials, support groups, and educational programs offered by hospitals and healthcare providers is assessed.

Furthermore, the analysis considers the affordability of care. The cost of prostate cancer treatment can be substantial, and the availability of financial assistance programs, insurance coverage, and payment options is a crucial factor in ensuring access to care for all patients, regardless of their socioeconomic status. The analysis examines the availability of resources to help patients navigate the financial aspects of their care.

The assessment also considers the use of advanced technologies in prostate cancer diagnosis and treatment. The availability of technologies such as MRI fusion biopsy, which combines MRI imaging with ultrasound guidance for more accurate prostate biopsies, and advanced radiation therapy techniques, such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT), is a key indicator of quality care.

The broader context of primary care availability in Washington, D.C., is also considered. The District's overall healthcare infrastructure, including the density of PCPs, the quality of hospitals, and the availability of specialized care, impacts the accessibility and quality of prostate cancer care within ZIP Code 20017. The analysis considers the District's healthcare landscape, including the presence of community health centers, free clinics, and other resources that may be available to patients.

The analysis does not focus on specific physician names or practice names to avoid any potential bias. Instead, the focus is on the overall healthcare ecosystem and the availability of resources for prostate cancer patients. The goal is to provide a comprehensive overview of the quality of care available in the area and to identify areas where improvements can be made.

In conclusion, the prostate cancer care landscape within ZIP Code 20017 and the broader context of primary care availability in Washington, D.C., is a complex interplay of physician availability, healthcare resources, and overall quality of care. The analysis highlights the importance of physician-to-patient ratios, standout practices, telemedicine adoption, mental health resources, and patient education and support. Understanding these factors is crucial for patients seeking the best possible care.

For a deeper understanding of the healthcare landscape in your area, including detailed maps of physician locations, healthcare resources, and demographic data, explore the interactive maps offered by CartoChrome.